UCB Disclosure Form For Purchase Of Celltech Group PLC (CLL) Shares
10/19/2005 5:11:43 PM
More...
|
Recommended Cash Offer For Celltech Group PLC (CLL) By UCB S.A.; 1.53 Billion Pounds ($2.71 Billion)
10/19/2005 5:11:23 PM
More...
|
Celltech Group PLC (CLL) Announces Completion Of Oxford GlycoSciences PLC (LS:OGS) Integration Process
10/19/2005 5:10:49 PM
More...
|
Celltech Group PLC (CLL): Closure Of Seattle Research Facility
10/19/2005 5:10:49 PM
More...
|
Pfizer Stalls Celltech Deal, Wants Bigger Profit Share
10/19/2005 5:10:48 PM
More...
|
Celltech Group PLC (CLL) Submits Xyrem For Approval In Europe
10/19/2005 5:10:39 PM
More...
|
Celltech Group PLC (CLL) Outlines Positive Preliminary Results From First CDP870 Phase III Trial In Rheumatoid Arthritis
10/19/2005 5:10:38 PM
More...
|
Celltech Group PLC (CLL): Update On CDP 870; Shares Plunge As Key Drug Delayed
10/19/2005 5:10:32 PM
More...
|
Celltech Group PLC (CLL) Close To Signing Arthritis Drug Deal
10/19/2005 5:10:27 PM
More...
|
Celltech Group PLC (CLL) And Biogen Idec, Inc. (Massachusetts) (BGEN) Announce Autoimmune Disease Collaboration
10/19/2005 5:09:56 PM
More...
|
|